ACTRN12622001172796尚未招募未知
Investigating the impact of a community pharmacy-based service on medication management amongst home-dwelling people living with dementia: a pilot study
niversity of New South Wales (UNSW)0 个研究点目标入组 25 人开始时间: 2022年8月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Educational / counselling / training
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Consumers with mild cognitive impairment, diagnosed or suspected dementia and home dwelling in the Perth metropolitan area. The inclusion criteria is also extended to the family carer if appropriate.
- •Pharmacists are to be community pharmacists with access to current Medscheck services in the Perth metropolitan area. The pharmacists will be currently registered to practise with the Australian Health Practitioner Regulation Agency.
排除标准
- •Pharmacists working only from aged care or hospitals are excluded from the study. Pharmacists outside of the Perth Metropolitan area or interstate will not be eligible for the study.
- •Consumers no longer able to provide consent due to their cognitive impairment. Consumers currently residing in an aged care facility will be excluded from the study. Consumers residing outside of the Perth Metropolitan area or interstate will not be eligible for the study.
研究者
相似试验
已完成
不适用
Evaluation of the use of a patient questionnaire in measuring patient reported outcomes of medication reviewsadverse drug reactions (ADRs), side effects of drugs, medication adherence (MARS), beliefs about medicines necessity and concerns (BMQ), self efficacy (MUSE)NL-OMON28732Radboud university medical center, Radboud Institute for Health Sciences, IQ Healthcare, Nijmegen, The Netherlands200
尚未招募
Unknown
Evaluation of efficacy of the community pharmacy intervention to optimize serum potassium levels in patients with chronic kidney diseasechronic kidney diseaseJPRN-UMIN000049814ational Hospital Organization Mie Chuo Medical Center40
招募中
不适用
Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease ProjectACTRN12609000705280Monash450
进行中（未招募）
不适用
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® [Paracetamol (500mg) and Pseudoephedrine (30mg)] on subjects with nasal congestion accompanied by headache in the setting of a common coldThe medical rationale = to investigate this combination drug in the symptomatic relief of common cold with nasal symptoms. The reduction of symptom severity may allow subjects receiving active medication to return to work or school earlier than those receiving placebo. To study the drug in it’s ‘natural environment’, community pharmacists will function as local investigators. They will include subjects with early (= 48 hours) cold symptoms of blocked nose with headache.EUCTR2006-000058-35-BEPfizer Consumer Healthcare Comm. VA/SCA
进行中（未招募）
不适用
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® (Paracetamol (500mg)/Pseudoephedrine (30mg)) on subjects with nasal congestion accompanied by headache and/or fever in the setting of a common coldMedical rationale= Investigation of combination drug Sinutab in symptomatic relief of common cold with nasal symptoms. Community pharmacists are considered as local investigators including subjects with early (= 48 hours) cold symptoms of blocked nose with headache and/or fever.EUCTR2004-001637-41-BEPfizer Consumer Healthcare cva/sca